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Abstract
The transcription factor AmrZ regulates genes important for P. aeruginosa virulence, including type IV pili, extracellular
polysaccharides, and the flagellum; however, the global effect of AmrZ on gene expression remains unknown, and
therefore, AmrZ may directly regulate many additional genes that are crucial for infection. Compared to the wild type strain,
a DamrZ mutant exhibits a rugose colony phenotype, which is commonly observed in variants that accumulate the
intracellular second messenger cyclic diguanylate (c-di-GMP). Cyclic di-GMP is produced by diguanylate cyclases (DGC) and
degraded by phosphodiesterases (PDE). We hypothesized that AmrZ limits the intracellular accumulation of c-di-GMP
through transcriptional repression of gene(s) encoding a DGC. In support of this, we observed elevated c-di-GMP in the
DamrZ mutant compared to the wild type strain. Consistent with other strains that accumulate c-di-GMP, when grown as a
biofilm, the DamrZ mutant formed larger microcolonies than the wild-type strain. This enhanced biofilm formation was
abrogated by expression of a PDE. To identify potential target DGCs, a ChIP-Seq was performed and identified regions of the
genome that are bound by AmrZ. RNA-Seq experiments revealed the entire AmrZ regulon, and characterized AmrZ as an
activator or repressor at each binding site. We identified an AmrZ-repressed DGC-encoding gene (PA4843) from this cohort,
which we named AmrZ dependent cyclase A (adcA). PAO1 overexpressing adcA accumulates 29-fold more c-di-GMP than
the wild type strain, confirming the cyclase activity of AdcA. In biofilm reactors, a DamrZ DadcA double mutant formed
smaller microcolonies than the single DamrZ mutant, indicating adcA is responsible for the hyper biofilm phenotype of the
DamrZ mutant. This study combined the techniques of ChIP-Seq and RNA-Seq to define the comprehensive regulon of a
bifunctional transcriptional regulator. Moreover, we identified a c-di-GMP mediated mechanism for AmrZ regulation of
biofilm formation and chronicity.
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Introduction
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen
that is a major burden on the health care industry. Up to 10% of
all nosocomial infections are attributed to P. aeruginosa, with
mortality rates approaching 40% in patients with bacteremia [1,2].
This bacterium is often a causative agent of sepsis, as well as acute
and chronic infections of the airway, burn wounds, skin, and
medical devices such as catheters [1,3].
Additionally, P. aeruginosa forms biofilms that contribute
significantly to disease [4]. The formation of a biofilm by P.
aeruginosa confers resistance to antibiotic treatment and immune
cells [5–7]. The classical definition of a biofilm involves a
community of bacteria adhered to a surface encased in a self-
produced matrix [3,8–11]. P. aeruginosa forms these biofilms in the
environment, on implanted devices such as catheters, and in
wound infections [12]. In addition, P. aeruginosa forms biofilms
suspended in the dehydrated pulmonary mucus plugs of cystic
fibrosis patients [13,14]. Biofilms are often recalcitrant to
antibiotics, have anti-phagocytic properties, and are difficult to
treat, commonly accounting for the persistence of chronic
infections [7,15–17].
Our laboratory has identified the ribbon-helix-helix transcrip-
tion factor AmrZ (alginate and motility regulator Z) as a
modulator of P. aeruginosa biofilm development and virulence
[18,19]. Five AmrZ-regulated virulence factors have been
identified through targeted molecular approaches; however, the
global effect of AmrZ on expression of P. aeruginosa genes is
unknown. AmrZ directly represses transcription of fleQ and thus
motility [20,21], and its own transcription in a feedback loop
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[22,23]. Additionally, AmrZ inhibits production of the extracel-
lular polysaccharide Psl by repressing transcription of the psl
operon [19]. In contrast, AmrZ activates alginate production by
binding the algD promoter [24,25] and is essential for twitching
motility and formation of a type IV pilus [26]. Each of these
AmrZ-regulated genes have been linked to biofilms and P.
aeruginosa pathogenicity. The major limitation of the previous
approaches is that they are biased towards genes that produce an
easily observed phenotype, potentially overlooking many AmrZ-
regulated genes that are important in infection. Here, we present a
systems-level analysis of the AmrZ regulon utilizing ChIP-Seq and
RNA-Seq [27,28]. By combining these two high-throughput
techniques, the genome can be scanned for functional AmrZ
binding sites. Additionally, these data allow classification of mem-
bers of the AmrZ regulon into activated or repressed promoters, as
well as direct vs. indirect regulation. Herein, we identified 398
regions of the genome bound by AmrZ ($3-fold enrichment). The
RNA-Seq identified 333 genes that were differentially expressed
when comparing a DamrZ mutant to a complemented strain ($2-
fold difference). Comparison of AmrZ-bound and AmrZ-regulated
genes identified 9 genes directly activated by AmrZ and 49 genes
that were directly repressed. Many of these genes have been
implicated in pathogenesis, highlighting the importance of AmrZ
in P. aeruginosa virulence. Finally, these data allow comparisons of
the sequence specificity of AmrZ bound promoters, further
defining the consensus AmrZ binding site and lending insight
into the mechanism of regulation by AmrZ.
One AmrZ-dependent pathway was investigated in detail since
it provided important insights into earlier findings that DamrZ
mutants form hyper biofilms compared with the parental strain,
PAO1 [19]. The present study provides a molecular basis for this
finding since we discovered that AmrZ directly represses a
predicted diguanylate cyclase-encoding gene (PA4843), which we
named adcA (AmrZ dependent cyclase A,). Repression of adcA led
to reduced amounts of the second messenger c-di-GMP. This
regulation event explains the hyper- aggregative and -biofilm
phenotype of a DamrZ strain, as elevated c-di-GMP is often
associated with the rugose small colony variant phenotype that
shares these characteristics [29–31]. Recent reports indicate that
reducing c-di-GMP in P. aeruginosa biofilm infections leads to
biofilm dissolution [32,33]. Regulation of c-di-GMP by AmrZ
could lend insights into the establishment and persistence of
chronic P. aeruginosa infections and open novel avenues of
treatment.
Results
amrZ mutants have an RSCV phenotype
Upon observation of overnight growth on VBMM, the wild-
type strain PAO1 formed a smooth colony, while the DamrZ
mutant formed an aggregated rugose small colony variant (RSCV)
morphology. (Figure 1A). Prevention of rugosity was dependent on
AmrZ binding DNA, as the DNA binding deficient R22A AmrZ
mutant is also an RSCV (Figure 1A). Chromosomal complemen-
tation of the DamrZ mutant relieves the rugose phenotype and
returns the colony morphology to that of the smooth parental
strain (Figure 1A). We have included the well-defined RSCV
DwspF for comparison [29,34,35]. The RSCV phenotype of the
DwspF mutant has been attributed to the loss of repression of the
diguanylate cyclase WspR, leading to elevated intracellular c-di-
GMP [32,36]. Cyclic di-GMP modulates the activity of the
transcriptional regulator FleQ at the pel locus, switching FleQ from
a repressor to an activator [37,38]. Psl and Pel polysaccharide
overproduction in these strains is responsible for the hyper
aggregative phenotype and rugose colony morphology observed
[35]. We therefore hypothesized that the DamrZ mutant displayed
a RSCV phenotype due to elevated intracellular c-di-GMP. To
test this, we purified nucleotide pools from plate-grown cells and
measured the c-di-GMP via LC-MS/MS (Figure 1B) [39]. We
observed that the DamrZ mutant accumulated nearly double the
intracellular c-di-GMP compared to parental wild type PAO1
(p#0.01). A two-fold change in c-di-GMP levels can have drastic
effects on cell physiology and biofilm formation [39–42]. These
data are consistent with our classification of DamrZ mutants as
RSCV. Additionally, we observed that the DNA binding deficient
R22A amrZ mutant had similar intracellular levels of c-di-GMP as
the DamrZ strain (data not shown), indicating that the AmrZ
contribution to low c-di-GMP is DNA binding dependent. This
observation, in combination with elevated c-di-GMP in the amrZ
mutants suggests that AmrZ-mediated modulation of c-di-GMP is
either through transcriptional repression of a diguanylate cyclase
or activation of a phosphodiesterase. Since AmrZ is a bifunctional
transcriptional regulator [22,24,25], either of these mechanisms is
possible. Therefore, to provide a comprehensive analysis of the
AmrZ regulon and to define the mechanistic basis for c-di-GMP
accumulation in the DamrZ mutant, RNA-Seq and ChIP-Seq
strategies were undertaken.
ChIP-Seq provides an unbiased analysis of AmrZ binding
to genomic DNA
Previous studies identified four AmrZ-bound promoters utilizing
standard molecular methods such as DNA footprinting and
Electrophoretic Mobility Shift Assays (EMSA) [18,19,22–26,43].
Though these methods are recognized as the standard for DNA
binding analysis, we wished to perform a genome-wide screen for
AmrZ binding sites. Chromatin immunoprecipitation (ChIP)
allows us to purify DNA bound AmrZ directly from cells
[27,28,44,45]. In this assay, chromatin bound AmrZ was cross-
linked, the DNA sheared, nonspecific proteins and nucleic acids
removed, and the DNA was purified and quantified using high-
throughput parallel DNA sequencing. The resulting ChIP-Seq
tags were analyzed using HOMER (Hypergeometric Optimization
of Motif EnRichment) a suite of tools for ChIP-Seq analysis and
Author Summary
Pathogenic bacteria such as Pseudomonas aeruginosa
utilize a wide variety of systems to sense and respond to
the changing conditions during an infection. When a stress
is sensed, signals are transmitted to impact expression of
many genes that allow the bacterium to adapt to the
changing conditions. AmrZ is a protein that regulates
production of several virulence-associated gene products,
though we predicted that its role in virulence was more
expansive than previously described. Transcription factors
such as AmrZ often affect the expression of a gene by
binding and promoting or inhibiting expression of the
target gene. Two global techniques were utilized to
determine where AmrZ binds in the genome, and what
effect AmrZ has once bound. This approach revealed that
AmrZ represses the production of a signaling molecule
called cyclic diguanylate, which is known to induce the
formation of difficult to treat communities of bacteria
called biofilms. This study also identified many novel
targets of AmrZ to promote future studies of this
regulator. Collectively, these data can be utilized to
develop treatments to inhibit biofilm formation during
devastating chronic infections.
AmrZ Regulon Defined in Pseudomonas aeruginosa
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motif discovery [46]. This generated a complete map of genomic
areas to which AmrZ binds (Table S1). Conditions were optimized
by using previously studied positive control DNA (algD, amrZ) and
a negative control region (algB) [22,24,25]. Consistent with the
literature, algD and amrZ promoters were significantly enriched
over input DNA (6.68 and 4.80 fold, respectively), while the algB
promoter demonstrated no significant enrichment compared to
input DNA. The previously published AmrZ interaction at the fleQ
and pslA promoters was also confirmed with this data set (Table 1),
indicating the stringency of the analysis. The relatively low
enrichment of these two previously described promoters by AmrZ
provides a reference to which other interactions can be compared,
suggesting that the interactions described here ($3-fold enrich-
ment) are biologically significant in the cell. In total, we identified
398 regions of the genome that were bound by AmrZ ($3-fold
enrichment over input) (Table S1).
Output for one significantly enriched region is included for
reference (Figure 2A). In this example, AmrZ binds upstream of
the PA4843 gene in the immunoprecipitated sample (green
histogram), however, this enrichment is not present in the input
sample (grey histogram). Other regions of the genome that were
bound by AmrZ appeared similar. Specific AmrZ binding to the
PA4843 promoter region was confirmed using an Electrophoretic
Mobility Shift Assay (Figure 2B).
AmrZ consensus binding site is defined
The ChIP-Seq analysis allows one to predict consensus-binding
sites based on identification of common sequences within enriched
DNA. Based on these analyses we defined a consensus AmrZ
binding site (Figure 3). The 13 nt motif was present in 54.7% of all
enriched DNA fragments, but in only 10.93% of background
reads, producing a significant enrichment of this sequence (p = 1e–
120). This motif resembles that reported elsewhere for AmrZ
binding using DNA binding and mutagenesis studies [18,23–
26,43]. This motif is also contained in the crystal structure of
AmrZ bound to the amrZ1 binding site identified by Pryor et al.
[23]. Putative AmrZ binding sites were assigned to a selection of
the AmrZ-enriched DNA fragments based on these consensus
sequences and analysis of ChIP-Seq reads.
Transcriptional profiling via RNA-Seq defines the AmrZ
regulon
Previous work demonstrated that AmrZ regulates genes in a
variety of pathways, many of which are implicated in virulence
[19,21,25,26]. However, the extent of the AmrZ regulon is
unknown. RNA-Seq allows comparison of sequences of the total
mRNA from a DamrZmutant to a complemented strain, elucidating
the effect of AmrZ on all genes in the cell, both positive and
negative. Total RNA was isolated from a mid-exponential culture
(OD600 0.560.1) of a DamrZ mutant containing the empty
pHERD20T vector and a complemented strain containing the
arabinose inducible AmrZ expression vector pCJ3. These growth
conditions were chosen to match those utilized in the ChIP-Seq
experiment. cDNA was synthesized and the resulting product was
tagged and quantified using high-throughput parallel DNA
sequencing. mRNA expression levels and differential expression
analysis was performed using the Bioconductor package DEseq [47].
Three hundred and thirty eight genes were significantly regulated at
least 2-fold (Benjamini-Hochberg adjusted p value ,0.05), with 89
genes activated- and 249 genes repressed- by AmrZ (Table S2).
Several of the AmrZ-regulated genes described in the literature
were identified in this analysis, including algD (activated by AmrZ
19.74 fold) and fleQ (repressed by AmrZ 8.05 fold).
The RNA-Seq data indicate that AmrZ strongly, though
indirectly, represses many genes involved in iron acquisition,
suggesting a novel mechanism for AmrZ mediated control of
virulence (Table 1). AmrZ significantly repressed many genes in
the pyochelin and pyoverdine synthesis operons, including ppyR. In
addition, the Fe(III)-pyochelin receptor fptA and ferripyoverdine
receptors fpvA and fpvB were all significantly repressed by AmrZ,
(5.44, 2.01, and 1.45 fold, respectively), suggesting that reliance on
the iron acquisition systems is reduced in strains where AmrZ is
highly expressed, such as in mucoid isolates from the CF lung.
Previous reports indicate that the iron concentration in the CF
sputum and lung is elevated [48-50], supporting the hypothesis
that there is sufficient iron in the CF lung for bacterial growth
with reduced dependence on the high-affinity iron acquisition
systems. Many virulence factors are iron-regulated, so the impact
of AmrZ-mediated siderophore repression may contribute signif-
icantly to the establishment of chronic infections [51,52]. There
Figure 1. amrZ mutants show characteristics of Rugose Small
Colony Variant Strains. A DamrZ mutants have RSCV pheno-
type. Images represent colony morphology after overnight growth on
VBMM agar. RSCV phenotype was observed in DamrZ and R22A DNA-
binding deficient amrZ mutants but not in the parental PAO1.
Chromosomal complementation of amrZ reverts the colony morphol-
ogy to that of the smooth parental PAO1. DwspF is included as a known
RSCV strain. Scale bars indicate 1 mm. B DamrZ mutants exhibit
increased intracellular c-di-GMP. Direct LC-MS/MS measurement of
c-di-GMP in plate-grown bacteria indicates that a DamrZ mutant
accumulates significantly more intracellular c-di-GMP than the wild-type
PAO1. The DNA binding deficient R22A AmrZ mutant has elevated c-di-
GMP. Individual measurements are displayed, along with mean and
standard error of the mean. Statistical significance was determined
using Student’s t-test. (** p#0.01, *** p#0.001).
doi:10.1371/journal.ppat.1003984.g001
AmrZ Regulon Defined in Pseudomonas aeruginosa
PLOS Pathogens | www.plospathogens.org 3 March 2014 | Volume 10 | Issue 3 | e1003984
was no alteration of the transcription of the iron-dependent master
regulator Fur in the DamrZ mutant, implying that AmrZ regulates
these iron acquisition genes independent of Fur, perhaps through
small RNAs or downstream members of the Fur regulon that have
yet to be identified. Future studies will explore the relationship of
AmrZ and iron acquisition during infection.
AmrZ directly regulates many genes associated with
virulence
The results from the RNA-Seq and ChIP-Seq were further
evaluated to determine genes potentially directly regulated by
AmrZ. To accomplish this, the list of AmrZ-bound genomic
regions (at least 3-fold enrichment) was filtered using the list of
target genes regulated by AmrZ as determined by the RNA-Seq
(at least 2-fold regulation). This approach allows classification of
genes based on AmrZ binding status and AmrZ-mediated
regulation. Interestingly, only 9 of the AmrZ-activated and 49 of
the AmrZ-repressed genes were identified in the ChIP-Seq as also
containing an AmrZ binding site within 500 base pairs of the start of
the coding region of the gene (Table 2), suggesting that there are 80
activated and 200 repressed genes with promoters that were not
directly bound by AmrZ, suggesting indirect regulation. One AmrZ
directly activated gene is algD, a known AmrZ-dependent gene [24].
Other AmrZ-activated genes in Table 2A include a putative
alginate lyase and members of the pel operon. These two genes, in
combination with activation of the algD operon, suggest that when
expressed, AmrZ affects the P. aeruginosa polysaccharide profile.
Additionally, AmrZ directly activates the cyclic di-GMP response
gene cdrA, which is correlated with polysaccharide overexpression
[30]. Table 2B depicts genes directly repressed by AmrZ. In
addition to the previously described fleQ, this list includes many
genes that are known or predicted to be involved in virulence
including: pyochelin synthesis (pchG), aggregation (siaA), flagellum
synthesis (fleQ, flgG, flgE, fliF), alternative type IV pili production (flp),
chemotaxis (PA2867, pctC, PA4844), multidrug transport (PA3401),
and rhamnolipid production and quorum sensing (rhlR). Several of
the directly AmrZ-repressed genes are predicted to be involved in
Type VI secretion: PA1657, PA1664, PA1668. Type VI secretion is a
recently-described system that is involved in P. aeruginosa pathogen-
esis and fratricide [53–56]. Specifically, the Type VI genes repressed
by AmrZ belong to the HSI-II locus, which is involved in P.
aeruginosa pathogenicity. HSI-II mutant strains exhibit a delay in
Table 1. RNA-Seq indicates AmrZ represses pyochelin and pyoverdine siderophore systems.
Gene Name Gene ID Gene Product RNA-Seq fold Change p-value
Pyochelin synthesis genes
pchC PA4229 pyochelin biosynthetic protein PchC 28.91 0.00000
pchG PA4224 pyochelin biosynthetic protein PchG 27.13 0.00000
pchB PA4230 isochorismate-pyruvate lyase 25.90 0.00000
pchF PA4225 pyochelin synthetase 25.09 0.00000
pchD PA4228 pyochelin biosynthesis protein PchD 24.25 0.00000
pchA PA4231 salicylate biosynthesis isochorismate synthase 24.17 0.00000
pchE PA4226 dihydroaeruginoic acid synthetase 24.02 0.00000
pchR PA4227 transcriptional regulator PchR 22.54 0.00000
Pyochelin receptor gene
fptA PA4221 Fe(III)-pyochelin outer membrane receptor 25.44 0.00000
Pyoverdine synthesis genes
pvdA PA2386 L-ornithine N5-oxygenase 22.94 0.00000
pvdQ PA2385 3-oxo-C12-homoserine lactone acylase PvdQ 21.99 0.00000
pvdP PA2392 protein PvdP 21.91 0.00000
pvdH PA2413 diaminobutyrate–2-oxoglutarate aminotransferase 21.76 0.00038
pvdS PA2426 extracytoplasmic-function sigma-70 factor 21.65 0.00116
pvdL PA2424 peptide synthase 21.57 0.00000
pvdR PA2389 protein PvdR 21.53 0.00095
pvdN PA2394 protein PvdN 21.50 0.00244
pvdJ PA2400 protein PvdJ 21.40 0.00014
pvdD PA2399 pyoverdine synthetase D 21.39 0.00014
pvdF PA2396 pyoverdine synthetase F 21.37 0.00347
pvdT PA2390 protein PvdT 21.35 0.01248
pvdE PA2397 pyoverdine biosynthesis protein PvdE 21.33 0.00364
Pyoverdine receptor genes
fpvA PA2398 ferripyoverdine receptor 22.01 0.00000
fpvB PA4168 second ferric pyoverdine receptor FpvB 21.45 0.00038
Pyoverdine regulator gene
ppyR PA2663 psl and pyoverdine operon regulator, PpyR 21.97 0.00000
doi:10.1371/journal.ppat.1003984.t001
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mortality in both murine lung and burn wound infections [54]. This
regulation may contribute to the role of AmrZ during infection.
Another group of AmrZ directly repressed genes are those
predicted to be involved in cyclic diguanylate signaling. These
include a predicted diguanylate cyclase (PA4843), a predicted
phosphodiesterase (PA2567), and hypothetical proteins that are
proposed c-di-GMP effector proteins containing PilZ domains
(PA4324, PA3353). PA4324 does not appear to be part of an
operon, while PA3353 is in the flgM operon and may have a
function in flagella motility [57]. Dysregulation of c-di-GMP
signaling could account for the hyper-aggregative phenotype of a
DamrZ mutant. We explore this system further in this study.
A common mechanism of AmrZ-mediated repression
Transcriptional start sites were obtained from RNA-Seq data by
observing where the sequence reads begin upstream of a coding
region [58]. By performing this analysis to a selection of directly
AmrZ-regulated promoters, the proximity of the AmrZ binding
site was observed relative to the transcription start site. Promoters
with strong AmrZ binding ($4-fold enrichment) and regulation
($4-fold regulation) were chosen for an alignment of the AmrZ
binding site to the start of transcription. The two strongly activated
promoters did not suggest a common mechanism (Figure 4A).
Figure 2. Analysis of ChIP-Seq and RNA-Seq data identifies AmrZ regulon. A Representative images of the Integrated Genome Viewer
software utilized to analyze sequencing data. Histograms comparing RNA sequence reads of arabinose-induced amrZ to DamrZ mutant strains are
colored blue. Histograms depict ChIP-Sequence reads for arabinose induced amrZ (green) and DamrZ mutant strains (grey). AmrZ binding (red) is
indicated in the promoter of PA4843 and PA4844 by observing $3 fold more sequence reads in the induced AmrZ ChIP sample compared to the
DamrZ mutant. B AmrZ specifically binds to the PA4843 promoter. A 168 bp DNA fragment was amplified from the PA4843 promoter containing the
AmrZ binding site discovered by ChIP-seq and labeled with 6FAM at the 59 end. Interaction between this fragment and purified AmrZ was measured
by EMSA (Electrophoretic Mobility Shift Assay; lanes 5–9). Each reaction contains 5 nM of FAM-labeled DNA, and increasing concentrations of AmrZ. A
174 bp DNA sequence within the algD coding sequence but lacking an AmrZ binding site was selected as the specificity control (lanes 1–4). The
AmrZ concentration for each lane is as below. Lanes 1–8 contain wild type AmrZ. Lane 1 and 5, 0 nM; lanes 2 and 6, 100 nM; lanes 3 and 7, 200 nM;
lanes 4 and 8, 400 nM. Lane 9 contains 400 nM of purified AmrZR22A (DNA binding deficient AmrZ).
doi:10.1371/journal.ppat.1003984.g002
Figure 3. ChIP-Seq reveals the AmrZ consensus-binding site.
Depiction of the consensus AmrZ binding site obtained by analyzing all
AmrZ-enriched sequences. Consensus sequence contains an A/T rich
region followed by GCC, followed by an A/T rich region. This sequence
was observed in 54.7% of AmrZ-bound DNA, with a p-value of 1e-120.
Motif analysis was performed utilizing tools within the HOMER analysis
package.
doi:10.1371/journal.ppat.1003984.g003
AmrZ Regulon Defined in Pseudomonas aeruginosa
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Table 2. Systems-level analysis of the AmrZ regulon.
A
Nearest Gene ID RNA-Seq Fold Change
ChIP-Seq Fold
Enrichment Gene Product
amrZ 483.31 4.80 alginate and motility regulator Z
PA1784 19.74 5.59 hypothetical protein-(homologous to Klebsiella alginate lyase)
pelB 6.64 5.76 PelB
PA0102 4.57 3.05 carbonic anhydrase
algD 3.79 6.68 GDP-mannose 6-dehydrogenase AlgD
PA1069 3.22 3.58 hypothetical protein
PA0082 2.84 7.94 TssA1 Type VI secretion
PA4625 2.84 4.24 CdrA
vreA 2.67 6.39 VreA
B
Nearest Gene ID RNA-Seq Fold Change
ChIP-Seq Fold
Enrichment Gene Product
PA4843 240.27 4.48 two-component response regulator
PA2867 214.89 9.60 chemotaxis transducer
PA1913 213.51 5.01 hypothetical protein (no prediction)
PA3691 211.66 3.31 hypothetical protein (no prediction)
PA5138 210.23 4.20 predicted ABC-type amino acid transport/signal transduction
PA3235 29.18 6.49 predicted membrane protein
PA4222 29.09 7.13 ABC transporter ATP-binding protein
PA4677 28.96 5.99 predicted dipeptidase
fleQ 28.05 3.00 transcriptional regulator FleQ
PA3234 27.63 3.88 acetate permease
pchG 27.13 13.60 pyochelin biosynthetic protein PchG
PA0172 26.59 11.93 SiaA SDS induced aggregation
PA5167 25.93 4.56 c4-dicarboxylate-binding protein
PA1657 25.31 3.72 HsiB2 (predicted Type VI secretion)
PA0038 25.12 7.13 hypothetical protein (no prediction)
PA3722 25.11 3.30 hypothetical protein (no prediction)
PA1941 24.87 3.28 hypothetical protein (no prediction)
PA4324 24.75 4.77 predicted PilZ domain
PA1680 24.56 6.48 predicted 3-oxoadipate enol-lactonase activity
PA0938 24.43 3.53 hypothetical protein (predicted exopolysaccharide chain length determinant
protein)
flgG 24.25 3.47 flagellar basal body rod protein FlgG
PA1199 24.04 4.33 lipoprotein
PA2462 23.75 4.89 hypothetical protein (contains type 1 export signal)
pctC 23.47 10.67 chemotactic transducer PctC
PA4683 23.32 4.87 hypothetical protein (no prediction)
flp 23.17 7.12 type IVb pilin, Flp
flgE 23.12 4.89 flagellar hook protein FlgE
PA4844 23.1 4.69 chemotaxis transducer
PA3367 23.02 3.17 hypothetical protein (contains type 1 export signal)
PA1340 23.01 5.87 amino acid ABC transporter membrane protein
PA3951 22.91 3.72 hypothetical protein (no prediction)
PA3413 22.90 3.30 predicted SOS response gene
rhlR 22.88 5.57 transcriptional regulator RhlR
PA1664 22.86 5.77 OrfX (secreted by Type VI)
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However, with the exception of PA3235, each of the directly
AmrZ-repressed promoters observed contained an AmrZ binding
site from 2100 to +15 relative to the transcription start site
(Figure 4B). This implies that during repression, AmrZ interferes
with the binding of RNA polymerase to the promoter, a common
mechanism of bacterial transcriptional repression.
Previous publications have identified two AmrZ binding sites in
the amrZ promoter, amrZ1 and amrZ2 [22,23]. The amrZ1 binding
site was identified by the ChIP-Seq (Figure 4B, red binding site).
The previously identified amrZ2-binding site was not specifically
identified by ChIP-Seq, however, this is likely due to the reduced
AmrZ affinity for the amrZ2 binding site [18,22]. Analysis of the
read alignment of the immunoprecipitated sample reveals a
biphasic peak including both the amrZ1 and amrZ2 binding sites.
One gene (PA3235) that was repressed by AmrZ lacked a binding
site in the promoter. However, AmrZ did bind 70 bp downstream
of the observed PA3235 start of transcription. This may indicate a
second mechanism of AmrZ repression, where bound AmrZ
interferes with the elongation of the transcript.
Analysis of the proximal promoter regions of AmrZ-regulated
genes indicates that AmrZ may affect RNA polymerase assembly
directed by several sigma factors. For example, the 210 and 235
boxes of siaA appear to indicate that this promoter is RpoD-
dependent (235TTGaCc/210TAtAAT), while the promoter of
PA4843 appears to match the consensus sequence for asN dependent
promoter (224GG/212GC) [59]. There was no discernable pattern
in the relation of the AmrZ binding site to the start of transcription in
the AmrZ-activated genes, indicating that there may be several
mechanisms of AmrZ-mediated direct activation.
adcA (PA4843) encodes a diguanylate cyclase
The gene most highly repressed by AmrZ was PA4843 (40-fold)
(Table 2B). Predictions based on the structure and function of
PleD from Caulobacter crescentus indicates that PA4843 contains two
component receiver domains (Rec), an I-site, and a GGEEF
cyclase domain (Figure S1). Previously, PA4843 was described as a
putative diguanylate cyclase [60] since it contains a conserved
cyclase domain; however, no reports demonstrate functional
cyclase activity for the PA4843-encoding gene. Additionally,
deletion of this gene in strain PA14 did not impact attachment
or host cell cytotoxicity [60]. Because PA4843 was the most highly
repressed AmrZ target gene and DamrZ mutants have an RSCV
phenotype and elevated levels of c-di-GMP (Figure 1B), we
hypothesized that PA4843 encoded a diguanylate cyclase that is
de-repressed in DamrZ mutants. To address this, PA4843 was
cloned into the arabinose inducible vector pHERD20T [61] and
the plasmids transferred to wild type PAO1 or a strain lacking
PA4843. c-di-GMP levels in both PAO1 or DPA4843 containing
the induced vector control exhibited low levels of c-di-GMP
(,3 fmol/mg total protein) (Figure 5). However, expression of
PA4843 in these strains generated nearly thirty fold more c-di-
GMP (87 fmol/mg total protein for PAO1, and 92 fmol/mg total
protein for DPA4843; Figure 5), supporting the hypothesis
that PA4843 is a functional diguanylate cyclase. Based on these
results and others below, we named PA4843 adcA, for AmrZ-
dependent cyclase A. Additionally, a deletion of adcA in a DamrZ
mutant returns the c-di-GMP to wild-type levels, (DamrZ mutant
7.33 fmol/mg total protein, DamrZ DadcA double mutant
2.33 fmol/mg total protein) indicating that the elevated c-di-
GMP in a DamrZ mutant is dependent on AdcA.
The DamrZ mutant hyper biofilm phenotype is adcA- and
c-di-GMP-dependent
As previously reported, a DamrZ mutant forms robust biofilms
with more biomass and taller microcolonies than the parental
strain, PAO1 [19]. This report demonstrated that direct repression
of the psl operon by AmrZ could abrogate the hyper biofilm
phenotype of the DamrZ mutant [19]. Here, we present data that
AmrZ also regulates c-di-GMP concentrations in the cell, thus
providing an additional level of control. We hypothesized that the
Table 2. Cont.
B
Nearest Gene ID RNA-Seq Fold Change
ChIP-Seq Fold
Enrichment Gene Product
PA4033 22.75 5.32 MucE
PA0494 22.73 8.98 acetyl-CoA carboxylase biotin carboxylase subunit
PA3353 22.73 4.04 predicted c-di-GMP binding protein
PA0472 22.61 3.51 RNA polymerase sigma factor FiuI, sigma 24 homolog
PA1088 22.56 4.94 Predicted magnesium protoporphyrin IX methyltransferase activity
PA2567 22.50 3.63 predicted phosphodiesterase
PA3401 22.41 8.88 predicted ABC-type multidrug transport system, permease component
fliF 22.38 5.49 flagellar MS-ring protein
phzA1 22.29 5.24 phenazine biosynthesis protein
ygbB 22.15 3.65 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
PA3019 22.09 17.74 ABC transporter ATP-binding protein
PA4980 22.09 7.55 enoyl-CoA hydratase
PA1939 22.07 3.96 predicted OLD family endonuclease
PA1668 22.04 6.17 DotU2 Type VI
PA1738 22.00 3.56 transcriptional regulator
ChIP-Seq identifies regions of the genome bound by AmrZ ($3-fold enrichment), while transcriptional profiling via RNA-Seq identifies differential regulation at these
genes ($2-fold regulation). A Table indicates genes directly activated by AmrZ. B Table indicates genes directly repressed by AmrZ.
doi:10.1371/journal.ppat.1003984.t002
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DamrZmutant hyper biofilm phenotype is due to adcA derepression
and c-di-GMP accumulation in this strain. To test this hypothesis,
we grew 24-hour flow cell biofilms in a PAO1 and DamrZ mutant
background while modulating the amount of adcA expression in
the cells (Figure 6A). We reasoned if the hyper biofilm phenotype
is dependent on derepression of adcA and accumulation of c-di-
GMP in the DamrZ mutant, biofilm cells formed by a DamrZ DadcA
double mutant should have less intracellular c-di-GMP and
biofilms with less biomass and microcolony height. Consistent
with this hypothesis, the DamrZ DadcA double mutant produces
biofilms with significantly less biomass than the DamrZ mutant
(Figure 6A, Figure S3). Additionally, we observed that the DamrZ
DadcA double mutant produced significantly lower c-di-GMP
compared to the DamrZ mutant (2.33 vs 5.98 fmol/mg total
protein, respectively) while the adcA overexpressing DamrZ mutant
had significantly higher c-di-GMP (67.00 fmol/mg total protein).
These data indicate that the hyper biofilm phenotype of the DamrZ
mutant is due to loss of repression of adcA and elevated
intracellular c-di-GMP. This mechanism, in addition to the
previously reported direct repression of the psl-encoded biofilm
polysaccharide [19], indicates that AmrZ-dependent regulation of
the psl operon at multiple levels may amplify the effect on Psl
production, with significant changes in the biofilm phenotype.
We also reasoned that if dysregulation of c-di-GMP production
is responsible for the hyper biofilm phenotype of DamrZ mutants,
then reducing intracellular c-di-GMP in these strains by overex-
pressing a phosphodiesterase (PDE) should ablate biofilm forma-
tion. For this, a plasmid encoding the arabinose inducible PDE
PA2133 (pJN2133) or the empty vector pHERD20T was trans-
formed into the DamrZ mutant and 16 hour flow cell biofilms were
grown in the presence of inducer [32]. CLSM analysis demon-
strates that PDE overexpression significantly reduces biofilm
biomass and microcolony height in these biofilms (Figure. 6B).
These data further support the hypothesis that the hyper biofilm
phenotype of DamrZ mutants is dependent on elevated c-di-GMP.
Discussion
Understanding how bacteria respond to varying conditions in
the environment and during infection is clearly of importance.
Here, we present a comprehensive analysis of a bacterial
transcription factor regulon obtained by combining ChIP-Seq
and RNA-Seq. The power of these techniques stems from the
unbiased and genome-wide production of the entire regulon, but
also the activity of the transcription factor at these binding sites.
These techniques have been established in eukaryotes [62,63],
however they have recently been adapted as powerful tools to
investigate the activity of bacterial transcription factors [27,28,
58,64–67]. We were able to identify 398 regions bound by AmrZ in
the P. aeruginosa genome. Additionally, we developed a transcrip-
tional profile of both the DamrZ mutant and its complemented
strain. This allowed us to combine the results of ChIP-Seq and
RNA-Seq and divide loci into several categories, either activated,
repressed, or unaffected by AmrZ. Each of these groups were then
further categorized into directly or indirectly regulated.
Our prior studies revealed that wild type bacteria have a
competitive advantage over DamrZ mutant bacteria in a mixed
acute pulmonary model of infection [18]. By combining ChIP-Seq
and RNA-Seq analysis, we identified many genes that are AmrZ-
regulated and may be important for colonization and disease
progression. One of the directly AmrZ-repressed genes, a
diguanylate cyclase we named adcA (PA4843), emerged as the
most highly regulated AmrZ target. Deletion of adcA in a DamrZ
mutant eliminated the accumulation of c-di-GMP and the hyper
biofilm phenotype. The modulation of c-di-GMP by AmrZ is a
novel observation and enhances the molecular explanation for the
earlier studies regarding the role of AmrZ in biofilm phenotypes
[19]. c-di-GMP has diverse functions in P. aeruginosa, regulating
polysaccharide production, motility, virulence factor production,
and biofilm formation [60,68]. When competed against the wild
type PAO1 in an acute pulmonary infection model, both a DadcA
mutant and a DamrZ DadcA double mutant retained the virulence
defect observed for the DamrZ mutant (Figure S2). We propose
that AmrZ-dependent gene regulation is most important in the
establishment of chronic infections, as in the cystic fibrosis lung.
Therefore, lack of a phenotype in an acute model of infection does
not negate a role for AmrZ in chronic infections and future studies
are geared towards this line of investigation. It should be noted
that suitable chronic lung infection models that faithfully
reproduce CF pathology are limited, though there are several
very promising developments in this area [69].
Regulation of the numerous DGC and PDE enzymes in
P. aeruginosa presents a complex network of integrated stimuli
sensation and physiological response. Work in other systems has
Figure 4. AmrZ binds near the start of transcription of repressed genes, but not activated genes. Promoter alignment of genes bound
by AmrZ ($4 fold enrichment) and A activated or B repressed ($4 fold regulation). Alignment of repressed genes implies a common mechanism for
AmrZ-mediated repression. Transcriptional start sites were called from RNA-Seq analysis. Sequences of AmrZ-repressed promoters are aligned at their
transcriptional start site (+1). The putative AmrZ binding site is indicated by red text. Blue text in the amrZ promoter indicates a second AmrZ binding
site, previously annotated AmrZ2. The promoter regions are indicated by grey shading.
doi:10.1371/journal.ppat.1003984.g004
Figure 5. PA4843 (adcA) encodes diguanylate cyclase. Expression
of adcA increases intracellular c-di-GMP. adcA was cloned into an
arabinose-inducible vector and strains were grown on LANS plates with
0.5% arabinose overnight. Direct LC-MS/MS measurement of c-di-GMP
revealed that both PAO1 and DadcA containing the empty vector (EV)
accumulated minimal amounts of c-di-GMP, while induction of adcA
(adcA+) was correlated with high accumulation of intracellular c-di-
GMP. Each graph point represents the average of three biological
replicate performed in triplicates. Significance determined using
Student’s t-test (*** p#0.001)
doi:10.1371/journal.ppat.1003984.g005
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Figure 6. The DamrZ mutant strain hyper biofilm phenotype is adcA dependent. A. Biofilm biomass and microcolony height correlate with
adcA expression. Orthogonal confocal laser scanning microscopy images of 24-hour flow cell biofilms are shown with Syto-9 stained biomass
depicted as green. Scale bars are in the upper right corner of each image and percent biomass (determined via COMSTAT analysis) relative to the
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demonstrated that c-di-GMP is freely diffusible in the cytoplasm
and is detected by many sensors [31,70,71]. This work highlights
the regulation of one DGC, however, deciphering the regulation
of c-di-GMP production and cellular response to diverse signals is
currently an area of great interest.
In addition to the DGC activity described here, AdcA
contains a predicted N-terminal two-component receiver
domain. This combination of receiver domain and DGC is also
observed in the well-characterized PleD of C. crescentus [72,73].
Previous studies have revealed PleC-dependent activation of the
PleD receiver domain by phosphorylation, leading to dimeriza-
tion and c-di-GMP production [72]. The end result of this
signaling cascade is the loss of flagellum and development of the
stalk leading to a sessile lifestyle. Another example of a hybrid
response regulator/diguanylate cyclase with biofilm effects is
WspR of P. aeruginosa [32]. Surface growth leads to phosphor-
ylation of WspR, inducing clustering of the protein and
activation of cyclase activity [74,75]. This model of clustered
cyclases suggests that such subcellular foci can lead to regional
increases of c-di-GMP, which may be an explanation for why
subtle changes in whole-cell c-di-GMP pools can have drastic
and varied effects on biofilm and motility phenotypes [73–76].
Analysis of AdcA for conserved domains indicates that the
aspartate at residue 300 is a probable phosphorylation site.
Activation of AdcA in P. aeruginosa leads to a hyper biofilm
phenotype, suggesting that AdcA, PleD, and WspR have similar
cellular effects. Based on the homology between these proteins,
future studies will identify the partner sensor kinase and
evaluate the effects of AdcA phosphorylation.
AmrZ activates alginate transcription and twitching motility,
but represses Psl, flagella, and c-di-GMP production (Figure 7).
Each of these pathways have been implicated in biofilm
formation and disease chronicity [77–85]. The complete analysis
of the AmrZ regulon indicates that AmrZ may serve as a
molecular switch that triggers biofilm maturation in P. aeruginosa.
We have observed that nonmucoid, environmental strains
produce a low amount of AmrZ, allowing for high production
of the adherent and aggregative polysaccharide Psl [19].
Additionally, low AmrZ in these strains allows expression of fleQ
and flagellum production, further enhancing the attachment
phenotypes [21,80]. We present here that low AmrZ also permits
expression of the diguanylate cyclase adcA, producing elevated c-
di-GMP in the cell. This signaling molecule can affect the
production of all of the above pathways in addition to the direct
regulation by AmrZ [29,32,37,38]. Cumulatively, the result of de-
repression of these genes results in a motile strain that is primed
to colonize and form biofilms by expressing the adhesive
polysaccharide Psl. We observe a hyper aggregative and hyper
biofilm phenotype in the DamrZ mutant, supporting this
hypothesis. A similar phenomenon is observed in a DretS mutant,
where elevated c-di-GMP leads to hyper biofilm formation
[40,86]. The GacS/RetS sensor systems are involved in the
transition from acute to chronic infections by regulating
polysaccharide production, motility, and secretion systems
[40,86,87]. These systems regulate virulence genes through
RsmA, which has a vast regulon [41,88]. Though AmrZ was
not identified as regulating any of the members of the Gac/Rsm
signaling cascade, the ultimate effects of the two pathways are
Figure 7. ChIP-Seq and RNA-Seq establish the AmrZ regulon. Direct (solid lines) and indirect (dashed lines) activity of AmrZ on various genes
involved in virulence. Current work has expanded the understanding of the AmrZ regulon to include several new systems, including iron acquisition,
type III secretion, type VI secretion, flagellum structure, Pel polysaccharide, and the biofilm structural protein CdrA.
doi:10.1371/journal.ppat.1003984.g007
DamrZ empty vector are indicated in the lower right corner. Significance was determined with Student’s t-test. (* p#0.05). B Expression of a
phosphodiesterase abrogates the DamrZ biofilm phenotype. Orthogonal confocal laser scanning microscopy images of 16-hour flow cell biofilms are
shown with Syto-9 stained biomass depicted as green. Scale bars are in the upper right corner of each image and percent biomass (determined via
COMSTAT analysis) relative to the DamrZ empty vector are indicated in the lower right corner. Biofilms were initiated and grown in the presence of
0.5% arabinose to induce expression of the phosphodiesterase PA2133 from the plasmid pJN2133. Significance determined with Student’s t-test. (*
p#0.05)
doi:10.1371/journal.ppat.1003984.g006
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strikingly similar. Further work will investigate how AmrZ is
interacting or overlapping with these well-established regulators
of acute to chronic transition. Identification of the signal
activating AdcA will enhance the understanding of the interac-
tions of these two functionally similar pathways.
Strains of P. aeruginosa that infect patients are Psl-producing,
nonmucoid, and form biofilms more readily than mucoid strains
[79,89]. Once a cystic fibrosis patient is infected with a
nonmucoid strain, there is an aggressive neutrophil influx into
the lungs [90]. These neutrophils produce many antimicrobial
products, including reactive oxygen species, antimicrobial pep-
tides, and neutrophil nets [91,92]. Additionally, CF patients with
active infections are treated with high doses of antibiotics. These
factors, coupled with the high salinity, low oxygen, and high
viscosity of the mucus in the CF lung, provide an environment
that is highly selective for bacterial variants able to persist [93].
One clear phenotype that emerges in this environment is the
production of alginate (mucoidy), which provides resistance to
phagocytosis and protection against antibiotics and reactive
oxygen species [7,16,94–96]. Mucoid strains express AmrZ at
levels much higher than those observed in nonmucoid counter-
parts [24,25,43]. We propose that AmrZ acts as a molecular
switch that transitions P. aeruginosa from a motile, adherent,
colonizing strain causing acute virulence and tissue damage to a
nonmotile, mucoid, chronic strain that is more adept at
persistence and immune evasion. We suggest that the enhanced
virulence of the wild type is due to the expression of various
virulence factors such as the type III secretion system regulator
ExsC and iron sequestration proteins such PchC and FptA.
AmrZ represses these genes (23.4, 29.01, and 25.45-fold,
respectively), though their promoters were not identified as bound
by AmrZ in the ChIP-Seq analysis, suggesting that this repression
is indirect. When AlgT/U is active, as in mucoid strains, the
amount of AmrZ rises. This rise in AmrZ could reduce
production of these proteins and limit the acute virulence of
the strains, allowing for the establishment of a chronic infection.
Additionally, we demonstrate that AmrZ activates expression of
cdrA, encoding a biofilm matrix protein and the pel polysaccharide
operon. Previous reports indicate that AmrZ can directly repress
the psl operon, leading to multifactorial control of this polysac-
charide [19]. Combined with the published knowledge of the
effect of c-di-GMP on the psl operon through FleQ, these data
further reinforce the potential for additive effects of AmrZ at
multiple points of polysaccharide and matrix protein regulation.
Cumulatively, these experiments suggest that the high production of
AmrZ in mucoid strains during chronic infections could lead to a
polysaccharide transition from expressing Psl to alginate and Pel.
Additionally, CdrA has been reported to stabilize biofilm structure
[30]. The overlap of these regulatory networks with the inclusion of
c-di-GMP signaling could provide insight to the complexity of the
contributions of polysaccharides to virulence during different stages
of infection. Future work will delve into virulence contribution by
the AmrZ-regulated genes to identify the molecular basis for the
acute virulence defect in the DamrZ mutant.
Materials and Methods
Ethics statement
All animals were maintained in the OSU College of Medicine
IACUC-approved vivarium located in the Biomedical Research
Tower. The University has many veterinarians and trained animal
caretakers available for consultation on the studies. The protocol
for these studies has been approved by the OSU IACUC
committee (Protocol # 2009A0177). There is adequate space for
the animals to be housed in the vivarium. Animals are monitored
frequently during the infection. Animals that meet the criteria
for removal from study will be euthanized via CO2 inhalation.
Each room contains sentinel mice that are sacrificed at regular
time points for examination for infectious agents by vivarium
staff. During infection, mice were lightly sedated with isoflurane
and inoculated intranasally with bacteria suspended in sterile
PBS. Thirty mL of the PBS solution is pipetted onto the nares of
the mouse as soon as the anesthetic administration is discon-
tinued. The animal rapidly recovers under supervision from the
researcher. The mice are not in discomfort or distress during this
procedure. There are no restraining devices utilized during this
study. Mice were sacrificed via CO2 inhalation. This method of
euthanasia causes minimal discomfort to the animals. Cardiac
puncture was used as a second method of euthanasia. These
methods are consistent with the recommendations of the
American Veterinary Medical Association Guidelines on Eutha-
nasia.
Bacterial strains and growth conditions
The bacterial strains used along with genotypes are provided in
Table S3. P. aeruginosa strains were inoculated in LBNS (10 g l21
tryptone, 5 g l21 yeast extract, pH 7.5) at 37uC for overnight
cultures under shaking conditions unless otherwise noted. Strains
were grown at 37uC on LANS (LBNS with 1.5% agar) or
Pseudomonas Isolation Agar (Difco, Detroit, MI) agar plates. E. coli
was routinely cultured at 37uC in lysogeny broth (LB, 10 g L21
tryptone, 5 g L21 yeast extract, 5 g L21 NaCl). Semi-solid media
was prepared by adding 1.5% Bacto agar to LB. Colony
morphology was imaged on modified Vogel-Bonner minimal
medium (VBMM) plates (0.2 g L21 MgSO4 7H2O, 2.0 g L
21
citric acid, 3.5 g L21 NaNH4HPO4 4H2O, and 10 g L
21
K2HPO4, 1 g L
21 casamino acids, and 5 mM CaCl2. Congo
Red (40 mg/mL) and Brilliant Blue R (15 mg/mL) were added to
VBMM to aid in visualization of morphology. Antibiotics were
added to maintain or select for plasmids in P. aeruginosa as follows:
gentamicin (Gm) at 100 mg/mL, Rifampicin (Rif) at 100 mg/mL
and carbenicillin (Cb) at 300 mg/mL. Antibiotics were added to
maintain or select for plasmids in E. coli as follows: gentamicin
(Gm) at 10 mg/mL and spectinomycin (Sp) at 50 mg/mL.
Plasmid construction
Plasmids and primers used in genetic manipulations are listed in
Tables S4 and S5, respectively.
Primers AmrZF2 and AmrZR2 amplified the 324 bp DNA
sequence of amrZ. NEB Q5 High Fidelity DNA Polymerase was
used in PCR following manufacturer’s instructions. The PCR
product of amrZ was inserted into pET29a (Novogen) through NdeI
and NotI restriction sites. The 432 bp DNA sequence of the amrZ
gene, ribosome binding site, and C-terminal 6x His tag were
amplified from the resulting plasmid using primers AmrZF3 and
AmrZR3. The PCR product was inserted into pHERD20T [61]
through XbaI and HindIII restriction sites. The resulting construct
(pCJ3) was verified by DNA sequencing.
A deletion allele for PA4843 was assembled by removing an in-
frame, 1593 bp fragment of coding sequence from the PA4843
open reading frame (ORF), leaving a scar ORF encoding a 10-
amino acid peptide. In a first step, two PCR products were
amplified using primers that targeted the adjacent upstream and
downstream regions of the chromosome flanking PA4843.
Subsequently, these PCR products were joined by splicing by
overlapping extension (SOE) PCR [97] to create the DPA4843
allele. The upstream forward and downstream reverse primers
used to generate this deletion allele were tailed with attB1 or attB2
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sequences as described in the Gateway Cloning Technology
Manual (Invitrogen). Using Gateway technology, the DPA4843
allele was first recombined with pDONR223 using BP Clonase II
(Invitrogen) to create pJJH125, which was sequenced using M13F
and M13R primers. Finally, the DPA4843 allele from pJJH125 was
recombined with pEX18GmGW using LR Clonase II (Invitrogen)
to create the allelic exchange vector pJJH129.
The adcA overexpression plasmid pBX22 was constructed by
inserting adcA coding sequence into the arabinose-inducible vector
pHERD20T [61]. The 1659 bp DNA sequence of the adcA gene
was amplified by primers PA4843_F and PA4843_R. NEB Q5
High Fidelity DNA Polymerase was used in PCR following
manufacturer’s instructions. The PCR product of adcA was
inserted into pHERD20T through XbaI and HindIII restriction
sites. The adcA coding sequence in pBX22 was verified by Sanger-
based DNA sequencing.
Quantification of c-di-GMP by LC/MS
c-di-GMP was extracted and quantified as described previously
with minor modifications [39]. Cells were cultured overnight on
LANS plates. An isolated colony was transferred to a fresh LANS
plate and incubated at 37uC for 24 hrs before harvesting. Colonies
were scraped from agar plates and resuspended in 990 mL of LC/
MS grade water (Optima). 2-chloro-adenosine-59-O-monophos-
phate (2Cl-AMP, 10 mL of 10 mM, Biolog), was added as an
internal standard. Nucleotides were extracted from cells by the
addition of 94 ml of 70% perchloric acid and incubated for 30 min
on ice. Cell debris were removed by centrifugation and reserved
for subsequent protein quantification. The supernatant containing
c-di-GMP was neutralized by the addition of 219 mL of 2.5 M
KHCO3. The resulting precipitate was removed by centrifugation.
The supernatant was stored at -80uC until LC/MS analysis. Pure
c-di-GMP standards (Biolog) were extracted in parallel and treated
identically to samples.
Compounds were separated on an Acuity UPLC equipped with
a C18 Guard Cartridge (Phenomenex) and Synergi 4 m Hydro RP
80A column (5062 mm, Phenomenex). The injection volume was
20–30 mL. A gradient was established starting with 98% aqueous
(10 mM formic acid in water) and 2% organic (acetonitrile). The
aqueous concentration was adjusted to 70% at 2 min, 20% at
2.5 min, 100% at 3 min, and finally held at 98% from 5–7.5 min.
Compounds were detected using multiple reaction monitoring on
a Premier XL triple-quadrupole electrospray mass spectrometer
(Waters) in positive-ionization mode. The m/z 691.152 transition
was used for the identification of c-di-GMP and 382.170 for 2Cl-
AMP. The cone voltages and collision energies were 40 V/30 eV
and 35 V/20 eV, respectively. The capillary voltage used was
3.5 kV. The desolvation temperature was 350uC and source
temperature was 120uC. Nitrogen was used as a drying gas with a
flow rate of 800 L/hr. The concentrations of c-di-GMP were
calculated by comparison of the peak area ratio of c-di-GMP to
2Cl-AMP to a standard curve. Moles of c-di-GMP were
normalized to total protein determined from Pierce protein assay.
Data represent averages of three independent cultures.
For protein quantification, cell pellets were resuspended
in 220 mL of 10 mM Tris-Cl buffer (pH 8.5). The remaining acid
in the pellets was neutralized by the addition of 30 ml of 1 M
NaOH. Cells were lysed by the addition of 250 ml of 2X
concentrated Laemilli Buffer and boiled for 30-90 min at 100uC
or until the pellet had dissolved. Protein concentration was
determined using Pierce 660 nm Protein Reagent with Ionic
Detergent Compatibility Reagent (IDCR) as recommended by the
manufacturer.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was modified from existing
protocols [44,45]. Cultures were induced with 0.5% arabinose at
an OD600 of 0.1 and allowed to grow for two hours at 37uC in a
roller. Protein-DNA complexes were cross-linked by addition of
formaldehyde- to a final concentration of 1.0% and incubated at
room temperature for ten minutes. Cross-linking was quenched by
addition of glycine (final concentration 250 mM). The final OD600
was recorded and cells were collected from 1 OD600 of culture via
centrifugation and washed once in LBNS. The supernatant was
removed and pellets were stored for further processing at -80uC.
Cell pellets were resuspended in 1.0 mL of lysis buffer (20 mM
HEPES, pH 7.9; 50 mM KCl; 0.5 mM DTT; 500 mM NaCl;
10 mM imidazole; 1% BSA; 1 mg/mL leupeptin/pepstatin; and
400 mM PMSF) per 1 OD600 of culture. Samples were sonicated
on Covaris with the following conditions: Duty Cycle 20%,
Intensity 8, Cycles per burst 200, with frequency sweeping 20 min
total shearing time (60 sec cycles, 20 cycles). Lysate was cleared via
centrifugation (20,0006 g, 30 minutes, 4uC) and the supernatant
was transferred to a fresh tube as the input sample. Magne-HIS
beads (Promega V8560) were blocked at room temperature in lysis
buffer for 30 minutes, and then 500 ml of the input sample was
added to the beads. After 30 minutes of binding at room
temperature with agitation, the supernatant was removed from the
beads via magnetic separation. Beads were washed five times in
wash buffer (100 mM HEPES, pH 7.5, 10 mM imidazole,
500 mM NaCl, and 1% BSA). Elution buffer (100 mM HEPES,
pH 7.5; and 500 mM imidazole) was added to the beads and
incubated at room temperature for 30 minutes. Supernatant was
collected after magnetic separation and combined with SDS
(1.25% final concentration), then heated to 70uC for 30 minutes to
reverse cross-links. DNA was purified via phenol:chloroform
extraction and ethanol precipitation [98].
ChIP-Seq library construction and sequencing
The chip DNA was quantified with Qubit 2 flurometer (Life
Technologies) using Qubit dsDNA BR Assay. 10 ng of DNA was
used to construct each Chip sequencing library, following
NEXTflex ChIP-Seq kit (Bioo Scientific) instruction. NEXTflex
ChIP-Seq Barcodes (Bioo Scientific) were used to index the
library. The final DNA libraries were validated with Agilent 2100
Bioanalyzer using Agilent High Sensitivity DNA Kit. And the
library concentrations were determined by Q-PCR using KAPA
SYBR Fast qPCR kit. The libraries were then run on Single End
flowcell on HiSeq2000.
ChIP-Seq data analysis
HiSeq2000 sequencing was performed, resulting in approxi-
mately 255 million total single-end 52 bp reads from the six
control and eight treatment samples. Reads were aligned using
bwa (0.5.10) to the Pseudomonas aeruginosa PAO1 reference genome
[99]. Approximately 220 million reads aligned uniquely to the
reference (86.3%). A TDF file was created for each sample for
visualization in IGV, which was scaled to reads per 10 million data
using bedtools (2.17.0) and igvtools (2.3.3). ChIP-Seq analysis was
performed using HOMER (4.2). First, aligned data was trans-
formed into a platform-independent data structure for further
HOMER analyses using the makeTagDirectory function. Secondly,
HOMER’s findPeaks-style factor was utilized to identify peaks, or
regions of the genome where more reads are present than random.
Lastly, HOMER’s findMotifsGenome.pl was used to analyze genomic
positions for de novo enriched motif regions of length 50 or 200 and
identified peaks were annotated with the motifs using the
annotatePeaks.pl function.
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RNA isolation
Cultures were induced with 0.5% arabinose at an OD600 of 0.1
and allowed to grow for two hours at 37uC in a roller. The final
OD600 was recorded and 0.1 OD600 was centrifuged at 10,000-x g
for 3 minutes. The supernatant was removed and pellets were
resuspended in 1 mL of TRIzol (Invitrogen). Following a 5-minute
incubation at room temperature, 0.2 mL of chloroform was added
and the samples were shaken for 15 minutes. Phases were
separated by centrifugation (12,0006 g, 5 minutes, 4uC) and the
aqueous phase was combined with 0.6 mL of 70% ethanol and
transferred to an RNeasy mini column (Qiagen). After centrifu-
gation, 0.7 mL of buffer RW1 (Qiagen) was added to the column
and centrifuged. Samples were washed twice with 0.5 mL of
Buffer RPE (Qiagen) and eluted in 50 mL of water.
RNA-Seq library construction and sequencing
Following assessment of the quality of total RNA using Agilent
2100 bioanalyzer and RNA Nano Chip kit (Agilent Technologies,
CA), rRNA was removed from 2.5 mg of RNA with Ribo-Zero
rRNA removal kit for Gram-negative bacteria (Epicentre
Biotechnologies, WI). To generate directional signal in RNA seq
data, libraries were constructed from first strand cDNA using
ScriptSeq v2 RNA-Seq library preparation kit (Epicentre Bio-
technologies, WI). Briefly, 50 ng of rRNA-depleted RNA was
fragmented and reverse transcribed using random primers
containing a 59 tagging sequence, followed by 39end tagging with
a terminal-tagging oligo to yield di-tagged, single-stranded cDNA.
Following purification by a magnetic-bead based approach, the di-
tagged cDNA was amplified by limit-cycle PCR using primer pairs
that anneal to tagging sequences and add adaptor sequences
required for sequencing cluster generation. Amplified RNA-seq
libraries were purified using AMPure XP System (Beckman
Coulter). Quality of libraries were determined via Agilent 2100
Bioanalyzer using DNA High Sensitivity Chip kit, and quantified
using Kappa SYBRFast qPCR kit (KAPA Biosystems, Inc, MA).
50 bp sequence reads were generated using the Illumina HiSeq
2000 platform.
RNA-Seq data analysis
HiSeq 2000 sequencing was performed, resulting in approxi-
mately 165 million total single-end 52-bp reads from the six total
control and treatment samples. Reads were aligned using bwa
(0.5.10) to the P. aeruginosa PAO1 reference genome [99].
Approximately 143 million reads aligned uniquely to non-
ribosomal regions of the reference (86.9%). A TDF file was
created for each sample for visualization in IGV, which was scaled
to reads per million data using bedtools (2.17.0) and igvtools
(2.3.3). A coverage file, describing the coverage for each feature in
the PAO1 genome, was created using bedtools. These coverage’s
were normalized and the means of the control and treatment
groups were tested for significant differences using the binomial
test in the R package DESeq (1.10.1), producing fold changes and
adjusted p-values for each feature. Resulting p-values were
adjusted for multiple testing with the Benjamin-Hochberg
procedure, which controls false discovery rate (FDR).
EMSA
6FAM labeled DNA used for EMSA was amplified using Quick-
load Taq 2X Mastermix (New England Biolabs), FAM-labeled
forward primer and non-labeled reverse primer, and PAO1
genomic DNA as the template. The EMSA procedure is similar to
that previously reported [18]. Each EMSA reaction contains
4 mM Tris-HCl (pH8.0), 40 mM NaCl, 4 mM MgCl2, 4%
glycerol, 150 ng/ul Poly d[(I-C)] (non-specific DNA control),
100 mg/mL BSA (non-specific protein control), 5 nM FAM
labeled DNA, and a defined concentrations of AmrZ or
AmrZR22A. Protein-DNA binding was equilibrated at room
temperature (25uC) for 20 min after adding all reagents to each
reaction. 10 mL of each reaction was loaded onto a 4% non-
denaturing acrylamide gel. Electrophoresis was conducted for
22 min at 200 V in 0.5% TBE. 6FAM fluorescence was detected
with a Typhoon scanner (GE Lifescience). A similar length DNA
sequence within the algD coding sequence but lacking an AmrZ
binding site was selected as the specificity control.
Protein structure and function prediction
Protein sequence was submitted to the Phyre2 server for analysis
of homology [100]. Predicted structure was imaged in Jmol
(http://www.jmol.org).
Flow cell biofilm study
Inoculation of flow cells was done by normalizing overnight
cultures to an optical density of 0.5 and injecting into an Ibidi m-
Slide VI0.4 (Ibidi 80601). To seed the flow cell surface, the media
flow was suspended and the bacteria allowed to adhere at room
temperature for 3 hours. Flow of 5% v/v LBNS with 0.5%
arabinose was initiated at a rate of 0.15 mL*min21 and continued
for 24 h. Following the biofilm growth period, the flow was
terminated and the biofilms were fixed with 4% paraformalde-
hyde. Confocal images were taken at the Ohio State University
Campus Microscopy and Imaging Facility on an Olympus
Fluoview 1000 Laser Scanning Confocal microscope. Images
were obtained with a 20X oil immersion objective. Images were
processed using the Olympus FV1000 Viewer software. Quanti-
tative analyses were performed using the COMSTAT software
package [101] Total biomass was determined from Z-stack images
using the BIOMASS command with the threshold set to 15. Three
independent biofilms were imaged and analyzed. Statistical
significance was determined using a Student’s t-test.
Supporting Information
Figure S1 A Phyre 2 structural model of AdcA. Structural
model of AdcA is based on similarities to PleD of C. crescentus.
Model is colored based on amino acid position, with the N-
terminus red and the C-terminus violet. Predicted cyclase active
site (GGEEF), allosteric inhibitory site (I-site), and two component
receiver domains (Rec domains) are indicated.
(TIFF)
Figure S2 AdcA is not responsible for the acute
virulence defect of a DamrZ mutant. Strains were
coinoculated intranasally at a 1:1 ratio (108 total bacteria). Lungs
were harvested, homogenized, and plated for CU at 24 hours post
infection. Competitive index is displayed, comparing the input
ratio of bacteria to the output ratio. Mean of the competitive index
of three independent experiments (n = 5) are displayed, comparing
input ratio of bacteria to output ratio of bacteria. Groups were
compared using the Student’s t-test. ns =No significant difference.
(TIFF)
Figure S3 Quantification of biofilm changes using
COMSTAT. Average total biomass of three biofilm images was
quantified for strains PAO1, DamrZ/pBADamrZ, and DamrZ
strains using COMSTAT. Student’s t-test was performed to
determine statistical differences among these strains (* p,0.05).
Unmarked comparisons are not statistically significant.
(TIFF)
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Table S1 ChIP-Seq data. List of all regions of the genome
significantly enriched for AmrZ binding as determined by ChIP-
Seq. ChIP-Seq fold enrichment indicates the change in detection
of a region comparing the sequences complexed to the induced
AmrZ to the input DNA from that sample. Predicted binding
motif is included. The closest predicted promoter to the predicted
binding site is listed. Expression fold change as determined by
RNA-Seq is included for each region, if significant.
(XLSX)
Table S2 RNA-Seq data. List of all genes whose expression is
significantly different comparing the complemented AmrZ strain
to the DamrZ mutant. Negative fold change indicates that the
expression was lower in the complemented strain than the mutant
(repressed by AmrZ), while positive fold change indicates that the
expression was higher in the complemented strain than the mutant
(activated by AmrZ).
(XLSX)
Table S3 Bacterial strains. List of bacterial strains used in
this study.
(DOCX)
Table S4 Plasmids. List of plasmids used in this study.
(DOCX)
Table S5 Primers. List of primers used in this study. *Regions
of identity to the target amplicons are underlined, regions of
reverse complementarity are italicized, and Gateway attB1 and
attB2 sequences are in bold.
(DOCX)
Supporting Methods S1 Methods utilized to produce
Supporting Information.
(DOCX)
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